Concentrix CNXC Q1 2026 Earnings EPS Miss and Revenue NonDisclosure Weigh on Sentiment Sera Prognostics Q1 2026 Earnings EPS In Line with Estimates as Stock Rises 15 Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting CRMT Q1 2026 Earnings Massive EPS Miss as Losses Widen Beyond Expectations CLDT Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Edges Higher RMCF Q1 2026 Earnings Loss per Share Narrows as Stock Gains 415